138 related articles for article (PubMed ID: 28414123)
1. Anti-factor Xa activities of zingerone with anti-platelet aggregation activity.
Lee W; Ku SK; Kim MA; Bae JS
Food Chem Toxicol; 2017 Jul; 105():186-193. PubMed ID: 28414123
[TBL] [Abstract][Full Text] [Related]
2. Novel direct factor Xa inhibitory compounds from Tenebrio molitor with anti-platelet aggregation activity.
Lee W; Kim MA; Park I; Hwang JS; Na M; Bae JS
Food Chem Toxicol; 2017 Nov; 109(Pt 1):19-27. PubMed ID: 28844963
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of novel factor Xa inhibitors from Oxya chinensis sinuosa with anti-platelet aggregation activity.
Lee W; Lee H; Kim MA; Choi J; Kim KM; Hwang JS; Na M; Bae JS
Sci Rep; 2017 Aug; 7(1):7934. PubMed ID: 28801633
[TBL] [Abstract][Full Text] [Related]
4. Novel factor Xa inhibitor, maslinic acid, with antiplatelet aggregation activity.
Kim KM; Kim J; Baek MC; Bae JS
J Cell Physiol; 2020 Dec; 235(12):9445-9456. PubMed ID: 32356316
[TBL] [Abstract][Full Text] [Related]
5. A Novel Direct Factor Xa Inhibitory Peptide with Anti-Platelet Aggregation Activity from Agkistrodon acutus Venom Hydrolysates.
Chen M; Ye X; Ming X; Chen Y; Wang Y; Su X; Su W; Kong Y
Sci Rep; 2015 Jun; 5():10846. PubMed ID: 26035670
[TBL] [Abstract][Full Text] [Related]
6. Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux.
Honda Y; Kamisato C; Morishima Y
Thromb Res; 2016 May; 141():17-21. PubMed ID: 26962981
[TBL] [Abstract][Full Text] [Related]
7. Renal protective effects of zingerone in a mouse model of sepsis.
Lee BS; Lee C; Yang S; Ku SK; Bae JS
BMB Rep; 2019 Apr; 52(4):271-276. PubMed ID: 30158024
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel selective factor Xa inhibitor, DJT06001, which reduces thrombus formation with low risk of bleeding.
Hu X; Xiao Y; Yu C; Zuo Y; Yang W; Wang X; Gu B; Li J
Eur J Pharmacol; 2018 Apr; 825():85-91. PubMed ID: 29475063
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
Petzold T; Thienel M; Dannenberg L; Mourikis P; Helten C; Ayhan A; M'Pembele R; Achilles A; Trojovky K; Konsek D; Zhang Z; Regenauer R; Pircher J; Ehrlich A; Lüsebrink E; Nicolai L; Stocker TJ; Brandl R; Röschenthaler F; Strecker J; Saleh I; Spannagl M; Mayr CH; Schiller HB; Jung C; Gerdes N; Hoffmann T; Levkau B; Hohlfeld T; Zeus T; Schulz C; Kelm M; Polzin A
Circ Res; 2020 Feb; 126(4):486-500. PubMed ID: 31859592
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Thrombin, Factor Xa and U46619 Inhibitory Effects of Non-Amidino and Amidino N²-Thiophenecarbonyl- and N²-Tosylanthranilamides.
Lee SH; Lee W; Nguyen T; Um IS; Bae JS; Ma E
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561744
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic activities of pellitorine in vitro and in vivo.
Ku SK; Lee IC; Kim JA; Bae JS
Fitoterapia; 2013 Dec; 91():1-8. PubMed ID: 23973654
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel, potent, isosteviol-based antithrombotic agents.
Chen P; Zhang D; Li M; Wu Q; Lam YPY; Guo Y; Chen C; Bai N; Malhotra S; Li W; O'Connor PB; Fu H
Eur J Med Chem; 2019 Dec; 183():111722. PubMed ID: 31563807
[TBL] [Abstract][Full Text] [Related]
13. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
Wong PC; Jiang X
Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
[TBL] [Abstract][Full Text] [Related]
14. Engineering Factor Xa Inhibitor with Multiple Platelet-Binding Sites Facilitates its Platelet Targeting.
Zhu Y; Li R; Lin Y; Shui M; Liu X; Chen H; Wang Y
Sci Rep; 2016 Jul; 6():29895. PubMed ID: 27432161
[TBL] [Abstract][Full Text] [Related]
15. Zingerone reduces HMGB1-mediated septic responses and improves survival in septic mice.
Lee W; Ku SK; Bae JS
Toxicol Appl Pharmacol; 2017 Aug; 329():202-211. PubMed ID: 28610995
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of factor Xa activity, platelet aggregation, and experimentally induced thrombosis by Sparstolonin B.
Kim N; Jeon C; Kim C; Ryu SH; Lee W; Bae JS
Phytomedicine; 2022 May; 99():153987. PubMed ID: 35183932
[TBL] [Abstract][Full Text] [Related]
17. Pre-clinical pharmacodynamic study of a novel oral factor Xa inhibitor zifaxaban.
Qiu X; Wang W; Zhao Z; Sun S; Tang L
Eur J Pharmacol; 2018 Oct; 836():50-56. PubMed ID: 30125563
[TBL] [Abstract][Full Text] [Related]
18. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
[TBL] [Abstract][Full Text] [Related]
19. Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivo.
Collin N; Assumpção TC; Mizurini DM; Gilmore DC; Dutra-Oliveira A; Kotsyfakis M; Sá-Nunes A; Teixeira C; Ribeiro JM; Monteiro RQ; Valenzuela JG; Francischetti IM
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2185-98. PubMed ID: 22796577
[TBL] [Abstract][Full Text] [Related]
20. DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles.
Furugohri T; Isobe K; Honda Y; Kamisato-Matsumoto C; Sugiyama N; Nagahara T; Morishima Y; Shibano T
J Thromb Haemost; 2008 Sep; 6(9):1542-9. PubMed ID: 18624979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
